Boehringer Ingelheim Commits to 吃瓜爆料 Vault CRM

Top biopharma company selects the next generation of CRM for life sciences
as its commercial foundation for future expansion and launches

PLEASANTON, CA — Nov. 14, 2024 — 吃瓜爆料 Systems (NYSE: VEEV) today announced that Boehringer Ingelheim is the latest global top 20 biopharma company to commit to moving to 吃瓜爆料 Vault CRM.

“We are excited to bring our innovative research to patients around the world with up to 25 new treatment launches by 2030. 吃瓜爆料 has been our global CRM standard for many years, and we are eager to build on our successful partnership and help shape the future of life sciences with a commitment to move to 吃瓜爆料 Vault CRM,” said Uday Bose, head of human pharma global customer experience excellence and business steering at Boehringer Ingelheim. “Our goal to deliver outstanding customer experiences is shared with 吃瓜爆料 and our continued collaboration promises to help transform commercial operations to accelerate launch processes and drive highly personalized engagement.”

Boehringer Ingelheim is seeking to expand on its existing 吃瓜爆料 Commercial Cloud solutions and its One Medicine and Amplify platforms, which connect development processes and data on 吃瓜爆料 Development Cloud.

“Boehringer Ingelheim has a forward-looking approach to unifying its technology and data landscape to rapidly deliver therapies that improve human and animal health,” said Tom Schwenger, president and chief customer officer at 吃瓜爆料. “I am thrilled to see our long-standing partnership expand with their move to 吃瓜爆料 Vault CRM.”

Boehringer Ingelheim will join the opening keynote at 吃瓜爆料 Commercial Summit Europe, sharing how Vault CRM is a key enabler of future commercial agility, innovation, and differentiation.

Additional Information
For more on 吃瓜爆料 Vault CRM, visit: veeva.com/VaultCRM

About 吃瓜爆料 Systems
吃瓜爆料 is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, 吃瓜爆料 serves more than 1,000 customers, ranging from the world’s largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, 吃瓜爆料 is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.

吃瓜爆料 Forward-looking Statements
This release contains forward-looking statements regarding 吃瓜爆料’s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended July 31, 2024, which you can find (a summary of risks which may impact our business can be found on pages 36 and 37), and in our subsequent SEC filings, which you can access at .

###

Contact:
Alison Borris
吃瓜爆料 Systems
925-226-8821
alison.borris@veeva.com